Avior Wealth Management LLC Raises Holdings in Axon Enterprise, Inc. (NASDAQ:AXON)

Avior Wealth Management LLC lifted its holdings in Axon Enterprise, Inc. (NASDAQ:AXON) by 3.0% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,995 shares of the biotechnology company’s stock after buying an additional 86 shares during the quarter. Avior Wealth Management LLC’s holdings in Axon Enterprise were worth $1,197,000 as of its most recent SEC filing.

Other institutional investors have also recently modified their holdings of the company. Quent Capital LLC boosted its position in shares of Axon Enterprise by 1,875.0% during the 3rd quarter. Quent Capital LLC now owns 79 shares of the biotechnology company’s stock worth $32,000 after purchasing an additional 75 shares in the last quarter. Blue Trust Inc. boosted its holdings in Axon Enterprise by 987.5% during the second quarter. Blue Trust Inc. now owns 87 shares of the biotechnology company’s stock worth $27,000 after buying an additional 79 shares in the last quarter. Planning Capital Management Corp grew its position in Axon Enterprise by 83.3% during the third quarter. Planning Capital Management Corp now owns 121 shares of the biotechnology company’s stock worth $48,000 after buying an additional 55 shares during the period. Friedenthal Financial purchased a new position in Axon Enterprise in the third quarter valued at about $51,000. Finally, Reston Wealth Management LLC acquired a new stake in shares of Axon Enterprise during the 3rd quarter valued at approximately $60,000. 79.08% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at Axon Enterprise

In other news, President Joshua Isner sold 20,000 shares of the stock in a transaction dated Tuesday, November 12th. The shares were sold at an average price of $606.15, for a total transaction of $12,123,000.00. Following the transaction, the president now directly owns 208,166 shares in the company, valued at $126,179,820.90. This represents a 8.77 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Julie A. Cullivan sold 900 shares of the firm’s stock in a transaction that occurred on Thursday, September 5th. The stock was sold at an average price of $353.53, for a total transaction of $318,177.00. Following the completion of the sale, the director now directly owns 3,653 shares in the company, valued at $1,291,445.09. This represents a 19.77 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 410,556 shares of company stock worth $161,192,754. 5.70% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

AXON has been the topic of a number of research reports. Robert W. Baird upped their price target on Axon Enterprise from $440.00 to $460.00 and gave the stock an “outperform” rating in a report on Monday, November 4th. JMP Securities upped their target price on Axon Enterprise from $430.00 to $500.00 and gave the company a “market outperform” rating in a report on Thursday, October 31st. Needham & Company LLC lifted their price target on Axon Enterprise from $525.00 to $600.00 and gave the stock a “buy” rating in a research note on Friday, November 8th. Barclays boosted their price objective on shares of Axon Enterprise from $381.00 to $387.00 and gave the stock an “overweight” rating in a research report on Wednesday, August 7th. Finally, The Goldman Sachs Group raised their target price on shares of Axon Enterprise from $385.00 to $441.00 and gave the company a “buy” rating in a report on Wednesday, October 23rd. Two equities research analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $427.83.

Axon Enterprise Trading Down 0.1 %

Shares of Axon Enterprise stock opened at $609.82 on Thursday. Axon Enterprise, Inc. has a fifty-two week low of $224.28 and a fifty-two week high of $624.84. The business’s fifty day moving average is $453.48 and its two-hundred day moving average is $363.68. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. The firm has a market cap of $46.50 billion, a PE ratio of 157.58, a P/E/G ratio of 15.05 and a beta of 0.94.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.